Re:The Web’s longest nightmare ends: Eolas patents are dead ...
by stephencanon on Tuesday July 23, 2013 @03:57PM
(#6092521)
Pharmaceuticals are a poor example because the (bulk of the) costs aren’t inherent to the discovery process, rather they are caused by the regulatory process that ensure safety for patients. I don’t see a good reason why that same regulatory process shouldn’t grant a limited monopoly instead of depending on patent protection.
Different fields of human invention have different economic characteristics. For a field where patents may be more economically useful than they are in software, consider the pharmaceutical industry. Developing a new drug costs a decade and hundreds of millions, and remains useful for a long time, but once developed is easily copied. None of those conditions are true for software (and there is no equivalent of copyright protection for drugs).
For more, try http://www.becker-posner-blog.com/2012/09/do-patent-and-copy...